
|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Closing the Gaps in Drug Chain of Custodyover 9 years ago
Data Unleashed: Cooperation Among Competitorsalmost 10 years ago
Raising the Stakes On Value-Based Pricingalmost 10 years ago
The Diversity Dearth in Pharmaalmost 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzalmost 10 years ago
R&D Model Mixes Compassion, Calculationalmost 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesalmost 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?almost 10 years ago
The Odd Couplealmost 10 years ago
Country Report: EgyptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
2
JP Morgan 2026: AbbVie Advances its Pipeline
3
JP Morgan 2026: Eli Lilly’s Continuing GLP-1 Success
4
JP Morgan 2026: Genmab Prioritizing Sustained Growth Over Next Decade
5




